New ray of hope for psychosis in parkinson’s: Pimavanserin.
Artículo
en Inglés
| IMSEAR
| ID: sea-178264
ABSTRACT
Parkinson’s disease is often associated with hallucinations and psychosis. Till now typical and atypical antipsychotics (Clozapine & Quetiapine) are being used to manage these symptoms. Recently US FDA has approved a new drug Pimavanserin for the treatment of hallucination and delusion associated with parkinson’s disease psychosis in a dose of 34 mg.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Idioma:
Inglés
Año:
2016
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS